Impact of the COVID-19 pandemic on the epidemiological surveillance systems of HIV infection in Spain
e202311093
Keywords:
Epidemiological surveillance, Impact of COVID-19, HIV infection, Reporting delay, Late diagnosisAbstract
BACKGROUND // The COVID-19 pandemic indirectly affected other communicable diseases, such as human immunodeficiency virus (HIV) infection. The aim of this paper was to evaluate the impact of the COVID-19 pandemic on the epidemiological surveillance of HIV through epidemiological indicators.
METHODS // Data collected in the New HIV Diagnosis Information System (SINIVIH, acronym in Spanish) in the period 2013-2021 was analyzed. The epidemiological indicators analyzed were: 1) Reporting delay of new diagnoses; 2) Under diagnosis of cases, calculated per month of diagnosis and for each year of diagnosis; 3) Late diagnosis, cases diagnosed with less than 350 CD4 cell/mm3.
RESULTS // Regarding the reporting delay of new diagnoses, in 2022 2,770 diagnoses were reported in 2020, 43.8% more than those reported in 2021 for that year. The cases diagnosed per month between 2016 and 2019 followed a constant trend. In 2020, a significant decrease in diagnoses was observed between March and May that was not recovered after correcting for reporting delay. When comparing the rates of cases diagnosed in 2013 with the successive years, a continuous decrease was interrupted in the last year of the study period. The percentage of cases with late diagnosis had remained stable in the study period (between 46% and 50%), and a decrease in this percentage was observed after correcting for reporting delay.
CONCLUSIONS // The epidemiological surveillance of HIV suffered a significant reporting delay. A decrease in cases diagnosed is confirmed, partly due to lockdown and lack of access to the health system. Changes on late diagnosis is not observed.
Downloads
References
The Lancet Public Health. COVID-19 in Spain: a predictable storm? Lancet Public Health. 2020;5(11):e568.
Moros MJS, Monge S, Rodriguez BS, Miguel LGS, Soria FS. COVID-19 in Spain: view from the eye of the storm. Lancet Public Health. 2021;6(1):e10.
Unidad de Vigilancia del VIH ITS y hepatitis B y C. Vigilancia epidemiológica del VIH y Sida en España. Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Madrid: Centro Nacional de Epidemiología-Instituto de Salud Carlos III/Plan Nacional sobre el Sida-S.G. de Promoción de la Salud y Vigilancia en Salud Pública; 2022.
Ministerio de Sanidad Servicios Sociales e Igualdad. Plan de prevención y control de la infección por el VIH y las ITS. 2021-2030 en España. Madrid; 2021.
European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2021-2020 data. Stockholm; 2021.
Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2021;16(1):63-73.
Hernando V, Reguero L, Belda J, Bru F, Lopez de Munain J, De La Torre JM et al. Impacto de la COVID-19 en los centros de atención a ITS/VIH en España: Indicadores de actividad. XII Congreso Nacional de Gesida. Enf Infecc Microbiol Clin. 2021;39(Esp Congreso 1):31.
Crane MA, Popovic A, Stolbach AI, Ghanem KG. Reporting of sexually transmitted infections during the COVID-19 pandemic. Sex Transm Infect. 2021;97(2):101-102.
Mitchell HD, Vilaplana TG, Mandal S, Ratna N, Glancy M, Shah A et al. Effects of COVID-19 Pandemic Response on Service Provision for Sexually Transmitted Infections, HIV, and Viral Hepatitis, England. Emerg Infect Dis. 2022;28(3):739-742.
Picchio CA, Valencia J, Doran J, Swan T, Pastor M, Martro E et al. The impact of the COVID-19 pandemic on harm reduction services in Spain. Harm Reduct J. 2020;17(1):87.
Sentis A, Prats-Uribe A, Lopez-Corbeto E, Montoro-Fernandez M, Nomah DK, Garcia de Olalla P et al. The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact? BMC Public Health. 2021;21(1):1637.
Simoes D, Stengaard AR, Combs L, Raben D, Euro TC-iacop. Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Euro Surveill. 2020;25(47).
Fernandez-Lopez L, Simoes D, Casabona J, Euro TC-IACoP. Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Eur J Public Health. 2023;33(3):528-535.
Ogunbodede OT, Zablotska-Manos I, Lewis DA. Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections. Curr Opin Infect Dis. 2021;34(1):56-61.
Gilbert M, Chang HJ, Ablona A, Salway T, Ogilvie GS, Wong J et al. Accessing needed sexual health services during the COVID-19 pandemic in British Columbia, Canada: a survey of sexual health service clients. Sex Transm Infect. 2022;98(5):360-365.
Joao AL, Lencastre A, Calvao J, Rodrigues A, Fernandes C. COVID-19, fear and sexual behaviour: a survey in a tertiary STI clinic in Lisbon. Sex Transm Infect. 2021;97(7):549.
Delpech V. The HIV epidemic: global and United Kingdom trends. Medicine (Abingdon). 2022;50(4):202-204.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53-60.
Plan Nacional sobre el Sida, Ministerio de Sanidad Servicios Sociales e Igualdad. Manual para la implementación del program de Profilaxis Pre-Exposición al VIH en España. Madrid; 2020.
Ministerio de Sanidad. Encuesta europea on-line para hombres que tienen sexo con hombres (EMIS-2017): resultados en España. Madrid; 2020.
Ferrer A, Oltra R, Ferrando R, Galindo MJ. Impacto de la pandemia COVID en el diagnóstico del VIH. XII Congreso Nacional de Gesida. Enf Infecc Microbiol Clin. 2021;39(Esp Congreso 1):31.
Sánchez L, Fernández M, Sáez de la Maleta R, Buzón LM, Navarro C. Nuevos diagnósticos de VIH (NDVIH): ¿En qué nos ha afectado la pandemia COVID-19? XII Congreso Nacional de Gesida. Enf Infecc Microbiol Clin. 2021;39(Esp Congreso 1):31.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Victoria Hernando Sebastián, Marta Ruiz-Algueró, Lorena Simón Méndez, Asunción Díaz Franco
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
